Richard Vanleeuwen, MD
Otolaryngology · Layton, UTNPI 1871584482
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,641 of the $1,884 with a category attached, or 87.1%. 14 manufacturers reported payments, led by Aerin Medical Inc. at 42.1% of the total. 2025 is the largest year on record at $1,184, more than ten times the $56 reported in 2019.
Across 78 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$793
- Sanofi$311
- Regeneron Healthcare Solutions, Inc.$212
- Optinose US, Inc.$111
- GSK$99
- Johnson & Johnson$81
- plus $277 from 8 others
What the payments were for
- Travel & lodging$24313%
- Food & beverage$1,64187%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 13 | $793 |
| Sanofi | 17 | $311 |
| Regeneron Healthcare Solutions, Inc. | 23 | $212 |
| Optinose US, Inc. | 6 | $111 |
| GSK | 6 | $99 |
| Johnson & Johnson | 1 | $81 |
| Medtronic | 3 | $78 |
| Innovation Technologies Inc | 1 | $43 |
| Amgen | 2 | $42 |
| Merck | 2 | $41 |
| Phadia US Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Stryker | 1 | $16 |
| Intersect ENT, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$366
How this compares
$1,884 in reported general payments places this provider in the 65th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 32 | $1,016 |
| Levothyroxine Sodium | 77 | $741 |
| Fluticasone Propionate | 41 | $683 |
| Omeprazole | 36 | $468 |
| Liothyronine Sodium | 17 | $417 |
| Mupirocin | 23 | $199 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $127 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $96 |
| Amoxicillin | 16 | $94 |
| Clonazepam | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Layton
- John BitnerLayton$177K
- Bryan RichardsLayton$6K
- Alexander RamirezLayton$2K
- Robert MellorLayton$2K
- Bryan WilcoxLayton$2K
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Kevin WilsonDraper$13K
- Jerry SonkensSlc$12K
- Matthew DahlSalt Lake City$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.